A first-in-human study of, NUC-7738, a 3’dA phosphoramidate, in patients with ad
- This topic has 0 replies, 1 voice, and was last updated 4 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
A first-in-human study of, NUC-7738, a 3’dA phosphoramidate, in patients with advanced solid tumors or lymphoma (NuTide 701).
http://abstracts.asco.org/239/AbstView_239_257501.html
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.